Outlook Therapeutics Statistics
NASDAQ: OTLKHealthcareBiotechnologyUSD
0.5989+0.0349 (+6.19%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Outlook Therapeutics by the numbers
Outlook Therapeutics has a market capitalization of $145.8 million based on 243.45M shares outstanding. With trailing EPS of $-0.74, Outlook Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.4% below its 50-day average and 15.7% below its 200-day average.
Average daily trading volume is 13.43M shares, or about $8.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OTLK valuation vs. peer median
| Metric | OTLK | Peer median | Difference |
|---|---|---|---|
| Market cap | $145.80M | $163.60M | -11% |
| Avg. volume | 13.43M | 432.80K | +3002% |
Peer median across 8 companies: TLSA, NKTX, ANTX, VRXA, PEPG, YARW, AARD, BMEA.
Valuation
- Market cap
- $145.80M
- EPS (TTM)
- $-0.74
- Shares outstanding
- 243.45M
Price and trading
- Previous close
- 0.564
- Open
- 0.5675
- Day range
- 0.5557 – 0.605
- 52-week range
- 0.161 – 2.54
- 52-week change
- -51.31%
- 50-day moving average
- 0.7252
- 200-day moving average
- 0.7105
- Beta
- —
- Volume
- 3.67M
- Average volume
- 13.43M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 145.80M
- Forward Pe
- -4.99
- Eps
- -0.74
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.54
- Week52 Low
- 0.16
- Avg Volume
- 13.43M
- Shares Outstanding
- 243.45M
- Ma50
- 0.73
- Ma200
- 0.71
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -76.40%
- Pct From52w Low
- 271.99%